TAAR1激动剂与D2受体阻断剂经不同纹状体神经元动力学调节产生抗精神病样效应
该研究在自由活动小鼠中,于正常及苯环己哌啶(PCP)诱导的精神病样状态下,考察TAAR1激动剂RO5166017和ulotaront对D1与D2受体表达型中等棘神经元(MSN)活体钙动力学的影响。两种TAAR1激动剂均减轻PCP引起的行为与MSN活动及时空动力学改变,其神经效应依赖运动活动与精神病样状态;而氟哌啶醇和氯氮平对MSN影响不同且缺乏明显状态依赖性。
要点
- TAAR1激动剂减轻PCP诱导的小鼠运动行为与MSN活动改变。
- TAAR1激动剂的神经效应依赖运动活动及精神病样状态。
- 氟哌啶醇和氯氮平对纹状体MSN影响与TAAR1激动剂不同且状态依赖性弱。
核心结论
- TAAR1激动剂的抗精神病样效应与D2受体阻断剂经不同的纹状体神经元动力学调节介导。
研究设计与样本
- 在自由活动小鼠中,于正常和PCP诱导的精神病样条件下,用活体钙成像记录D1与D2受体表达型MSN动力学。
主要发现
- ulotaront和RO5166017均减轻PCP诱导的运动行为、MSN活动水平及时空动力学改变。
- TAAR1激动剂的神经效应依赖运动活动和精神病样状态。
- 正常条件下两种TAAR1激动剂对神经元活动水平影响不同,但在PCP状态下于运动期间均产生相似增加。
- 氟哌啶醇和氯氮平产生相似行为效应,但对纹状体MSN影响不同且缺乏明显状态依赖性。
临床怎么用
- 提示TAAR1激动剂与D2受体阻断剂抗精神病样作用涉及不同神经环路机制,支持TAAR1激动剂作为机制不同的新治疗方向。
局限性
- 研究为小鼠在体钙成像,结论向人类精神分裂症临床外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Trace amine-associated receptor 1 (TAAR1) agonists are being investigated as potential new treatments for schizophrenia, a disorder characterized by striatal hyperdopaminergia and dysregulated cortical and hippocampal glutamatergic function. Current evidence suggests that TAAR1 agonists reduce elevated striatal dopamine synthesis capacity and release, likely through direct inhibition of presynaptic dopaminergic neurons and modulation of upstream glutamatergic signaling. However, their impact on postsynaptic striatal neuronal dynamics and associated behaviors remains largely unexplored. Here we investigated the effects of TAAR1 agonists, RO5166017 and clinical drug candidate ulotaront, on in vivo calcium dynamics of D1- and D2-receptor expressing medium spiny neurons (MSNs) in freely behaving mice, under normal and phencyclidine (PCP)-induced, psychosis-like conditions. Both ulotaront and RO5166017 mitigated PCP-induced alterations in locomotor behavior, MSN activity levels and spatiotemporal dynamics. Interestingly, the neural effects were dependent on both locomotor activity and the psychosis-like state. While ulotaront and RO5166017 differentially affected neuronal activity levels under normal conditions, they both produced a similar increase in the PCP state, specifically during movement, with comparable effects observed in D1 and D2 MSNs. Although the established antipsychotics haloperidol and clozapine produced similar behavioral effects, their impact on striatal MSNs was distinct and lacked prominent state dependence. These findings provide new insights into the distinct neurocircuit changes associated with the antipsychotic-like effects of TAAR1 agonists, distinguishing them from D2 receptor-targeting treatments.
引用
- Huang S, Yang SM, Bellier L, et al. Antipsychotic-like effects of TAAR1 agonists and D2 receptor blockers are mediated through distinct modulation of striatal neuronal dynamics. Mol Psychiatry. 2026. PMID: 42481744. doi:10.1038/s41380-026-03724-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。